{"id":13,"date":"2026-02-02T14:43:44","date_gmt":"2026-02-02T14:43:44","guid":{"rendered":"https:\/\/admarebio.com\/?page_id=13"},"modified":"2026-07-27T14:56:48","modified_gmt":"2026-07-27T14:56:48","slug":"early-stage-capital","status":"publish","type":"page","link":"https:\/\/admarebio.com\/en\/building-companies\/early-stage-capital\/","title":{"rendered":"Early-Stage Capital"},"content":{"rendered":"\n
\"\"<\/span>
\n
\n

Building strong, investable Canadian life sciences companies.<\/h1>\n\n\n\n
\n

adMare’s unique model helps to validate, incubate and accelerate growth. It is intentionally flexible, with supports adapted to meet the unique needs and stages of each opportunity.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n

Our approach<\/h2>\n\n\n\n
\n
\n
\n
\n
\n

Validation<\/h3>\n\n\n\n

We provide meaningful pre-seed capital and drug development expertise to generate critical scientific data.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Incubation<\/h3>\n\n\n\n

We provide seed capital and early operational support to advance R&D, strengthen IP and enhance investment readiness.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Acceleration<\/h3>\n\n\n\n

We provide follow-on investment, a strong investor network and continued expert guidance to support Series fundraising and key inflection points.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

adMare\u2019s portfolio<\/h2>\n\n\n\n

adMare has helped build 54 companies that have raised $2.5 billion in real risk capital, have a combined value of $5.8 billion and created about 1000 jobs across Canada.<\/p>\n\n\n\n

\n
View portfolio<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Our investment scope<\/h2>\n\n\n\n

adMare currently invests in highly-differentiated therapeutic innovations that address unmet patient needs.<\/p>\n<\/div>\n\n\n\n

\n
\n
\n

Our investment criteria includes:<\/strong><\/h3>\n\n\n\n
\n
\n